At PrimeHealthMD, a leading weight loss clinic in Atlanta, Alpharetta, Dunwoody, and Kennesaw, we understand that weight management is not a one-size-fits-all journey
Eli Lilly's tirzepatide products, Mounjaro and Zepbound, are growing fast in market share and are projected to overtake semaglutide as the leading GLP-1 drug within the next few years, though semaglutide still holds the largest overall proportion at the time of writing
Both act on the same growth hormone pathway, so dosing and timing should be guided by a clinician who reviews your labs, symptoms, and health history first
If the treat you want is something youll truly remember in two weeks, then go for it
This was not observed at the same rate in Phase 2, so it will be monitored closely in the remaining Phase 3 studies
Prevention of cardiorenal complications in people with type 2 diabetes and obesity